References
- Dubinsky RM, Kabbani H, El-Chami Z, et al. Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004;63:959-965
- Stankus SJ, Dlugopolski M, Packer D. Management of herpes zoster (shingles) and postherpetic neuralgia. Am Fam Physician 2000;61:2437-2444, 2447-2448
- Kost RG, Straus SE. Postherpetic neuralgia – pathogenesis, treatment, and prevention. N Engl J Med 1996;335:32-42
- Dworkin RH, White R, O’Connor AB, et al. Health care expenditure burden of persisting herpes zoster pain. Pain Med 2008;9:348-353
- Rowbotham MC, Davies PS, Verkempinck C, et al. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996;65:39-44
- Galer BS, Rowbotham MC, Perander J, et al. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 1999;80:533-538
- Galer BS, Jensen MP, Ma T, et al. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain 2002;18:297-301
- Dworkin RH, Schmader KE. Treatment and prevention of postherpetic neuralgia. Clin Infect Dis 2003;36:877-882. Epub 2003, Mar 13. Review
- Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003;60:1524-1534. Review
- Holahan J, Miller DM, Rousseau D. Dual eligibles: Medicaid enrollment and spending for Medicare beneficiaries in 2005. Kaiser Commission on Medicaid and the Uninsured Issue Brief, February 2009
- O’Brian E, Elias R. Medicaid and long-term care. Kaiser Commission on Medicaid and the Uninsured, May 2004
- Tyring S. Management of herpes zoster and postherpetic neuralgia. J Am Acad Dermatol 2007;57:s136-142
- Gnann JW, Whitley RJ. Herpes zoster. N Engl J Med 2002;347:340-346
- Dworkin RH, White R, O’Connor AB, et al. Healthcare costs of acute and chronic pain associated with a diagnosis of herpes zoster. J Am Geriatr Soc 2007;55:1168-1175
- Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383
- Romano PS, Roos LL, Jollis J. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data. J Clin Epidemiol 1993;46:1075-1079
- Rascati KL, Smith MJ, Neilands T. Dealing with skewed data: an example using asthma-related costs of Medicaid clients. Clin Ther 2001;23:481-498
- Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York: Chapman & Hall, 1993
- SAS Institute. Jackknife and Bootstrap Analyses. http://support.sas.com/kb/24/982.html
- Gauthier A, Breuer J, Carrington D, et al. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect 2009;137:38-47. Epub 2008, May 9
- Rothberg MB, Virapongse A, Smith KJ. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Clin Infect Dis 2007;44:1280-1288
- Harpaz R, Ortega-Sanchez IR, Seward JF. Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008;57:1-30
- Faught E, Duh MS, Weiner JR, et al. Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM Study. Neurology 2008;71:1572-1578. Epub 2008, Jun 18
- Faught RE, Weiner JR, Guérin A, et al. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study. Epilepsia 2009;50:501-509. Epub 2008, Oct 3
- Wu EQ, Shi L, Birnbaum H, et al. Annual prevalence of diagnosed schizophrenia in the USA: a claims data analysis approach. Psychol Med 2006;36:1535-1540. Epub 2006, Aug 15
- Yu AP, Ben-Hamadi R, Birnbaum HG, et al. Comparing the treatment patterns of patients with schizophrenia treated with olanzapine and quetiapine i the Pennsylvania Medicaid population. Curr Med Res Opin 2009;25:755-764
- Yu AP, Atanasov P, Ben-Hamadi R, et al. Resource utilization and costs of schizophrenia patients treated with olanzapine versus quetiapine in a Medicaid population. Value Health 2009;12:708-715